LY86 and cardiac hypertrophy: Here we reported that both NF‐κB and MAPK were activated by high‐fat stimulation in vivo and in vitro, and inhibiting them with corresponding inhibitors ameliorated cardiac hypertrophy and fibrosis in MD‐1 deletion mice.